Jeffrey Sunman, Ph.D., is involved in patent drafting and patent prosecution in the areas of biotechnology, pharmacology and life sciences. Dr. Sunman received his B.S. in biology from Stetson University and his Ph.D. in pharmaceutical sciences from Mercer University. Dr. Sunman completed postdoctoral fellowships at the University of North Carolina at Chapel Hill and at the National Institute of Environmental Health Sciences.
Dr. Sunman’s research has focused on various aspects of pharmacology, drug metabolism and cancer biology. As a graduate student, he characterized novel inhibitors of peptide alpha-amidation in models of inflammation and tumorgenesis. As a postdoctoral fellow at UNC, he studied changes in hepatic enzyme activity in hepatitis C virus-infected liver, as well as the role of arachidonic acid-metabolizing cytochrome P450 enzymes in the survival of primary hepatocytes. As a postdoctoral fellow at NIEHS, Dr. Sunman utilized lentivirus-based protein expression techniques and structure-function analyses to identify novel mechanisms by which proteases in the tumor microenvironment induce integrin-dependent cell migration during metastasis.
His academic research experience encompassed the fields of molecular and cellular biology, pharmacology, cancer biology and drug metabolism and disposition, leading to co-authored publications in peer-reviewed journals including the Journal of Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition, Molecular Carcinogenesis, Developmental Biology, and Cell Biology and Toxicology.